SCHEMBL7959702

SCHEMBL7959702

Brc1ccc(C2CCN(CCCc3nnc4n3CCCCC4)CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.51
GAA P10253 1/20 0.51
HPGD P15428 3/20 0.46
ALDH1A1 P00352 1/20 0.46
CHRM2 P08172 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA1D P25100 1/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
SLC6A4 P31645 1/20 0.43
ADRA1A P35348 1/20 0.43
DRD3 P35462 1/20 0.43
HTR2B P41595 1/20 0.43
POLB P06746 1/20 0.42
SIGMAR1 Q99720 2/20 0.41
HRH3 Q9Y5N1 3/20 0.39
KCNH2 Q12809 2/20 0.39
CYP3A4 P08684 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957664 0.89 KDM4E (0.51) TSHRHPGDCHRM2HTR1AADRA2A
SCHEMBL7957361 0.89 DRD2 (0.48) GAAHPGDCHRM2HTR1AADRA2A
SCHEMBL7957315 0.89 LMNA (0.51) CHRM2HTR1AADRA2AADRA2BADRA1D
Hydrochloric Acid SCHEMBL8570980 0.88 DRD2 (0.47) GAAHPGDCHRM2HTR1AADRA2A
SCHEMBL7949249 0.86 DRD2 (0.51) HPGDCHRM2HTR1AADRA2AADRA2B
SCHEMBL7959711 0.83 SLC6A4 (0.51) TSHRGAAHPGDCHRM2HTR1A
SCHEMBL7959264 0.82 LMNA (0.53) GAAHPGDCHRM2HTR1AADRA2A
SCHEMBL7959555 0.82 LMNA (0.46) TSHRGAAHPGDCHRM2HTR1A
SCHEMBL7964136 0.81 GAA (0.52) GAAHPGDALDH1A1CHRM2HTR1A
SCHEMBL7964120 0.81 CHRM2 (0.42) TSHRGAAHPGDCHRM2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed